Cargando…

Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020

Breakthrough candidemia (BrC) is a significant problem in immunocompromised patients, particularly those with hematological disorders. To assess the characteristics of BrC in patients with hematologic disease treated with novel antifungal agents, we collected clinical and microbiological information...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishida, Ruriko, Eriguchi, Yoshihiro, Miyake, Noriko, Nagasaki, Yoji, Yonekawa, Akiko, Mori, Yasuo, Kato, Koji, Akashi, Koichi, Shimono, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294639/ https://www.ncbi.nlm.nih.gov/pubmed/37312399 http://dx.doi.org/10.1093/mmy/myad056

Ejemplares similares

Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients
por: Chong, Yong, et al.
Publicado: (2020)

Platypnea-Orthodeoxia Syndrome in Coronavirus Disease 2019 Pneumonia: A Case Report and Literature Review
por: Tanimoto, Takahiko, et al.
Publicado: (2023)

Helicobacter cinaedi Bacteremia Mimicking a Flare of Systemic Lupus Erythematosus
por: Nishida, Ruriko, et al.
Publicado: (2017)

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay
por: Toyoda, Mako, et al.
Publicado: (2023)

Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529)
por: Yonekawa, Akiko, et al.
Publicado: (2022)

Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
por: Chong, Yong, et al.
Publicado: (2022)

Pronounced antibody elevation after SARS‐CoV‐2 BNT162b2 mRNA booster vaccination in nursing home residents
por: Chong, Yong, et al.
Publicado: (2022)

Achievement of sufficient antibody response after a fourth dose of wild‐type SARS‐CoV‐2 mRNA vaccine in nursing home residents
por: Chong, Yong, et al.
Publicado: (2023)

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
por: Chong, Yong, et al.
Publicado: (2017)

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013)

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
por: Goto, Takeyuki, et al.
Publicado: (2022)

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study
por: Sumida, Kosuke, et al.
Publicado: (2015)

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients
por: Cugno, Chiara, et al.
Publicado: (2012)

P413 Screening and diagnosis of Candidemia in adult hematological malignancies of northern India
por: Banerjee, Gopa, et al.
Publicado: (2022)

Invasive meningococcal disease due to a non-capsulated Neisseria meningitidis strain in a patient with IgG4-related disease
por: Kurose, Shun, et al.
Publicado: (2018)

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
por: Stadtmauer, Edward, et al.
Publicado: (2017)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Pyruvate kinase activator: A major breakthrough in the world of Hematology
por: Iqbal, Amna, et al.
Publicado: (2022)

Candidemia in Children with Malignancies: Report from the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology
por: Vasileiou, Eleni, et al.
Publicado: (2020)

Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015)

Candidemia en Colombia
por: Cortés, Jorge Alberto, et al.
Publicado: (2020)

1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)

Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan
por: Hirano, Ryuichi, et al.
Publicado: (2018)

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
por: Pagano, Livio, et al.
Publicado: (2022)

Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate
por: Iwasaka, Sho, et al.
Publicado: (2020)

Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan
por: Chong, Yong, et al.
Publicado: (2021)

Candida dubliniensis candidemia in Australia.
por: Marriott, D, et al.
Publicado: (2001)

Active Surveillance of Candidemia, Australia
por: Chen, Sharon, et al.
Publicado: (2006)

Candidemia in Finland, 1995–1999
por: Poikonen, Eira, et al.
Publicado: (2003)

Epidemiological Trends of Candidemia and the Impact of Adherence to the Candidemia Guideline: Six-Year Single-Center Experience
por: Kim, Jong Hun, et al.
Publicado: (2021)

Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia
por: Colburn, Nora, et al.
Publicado: (2022)

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy
por: Nomoto, Haruka, et al.
Publicado: (2019)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

2696. Breakthrough Toxoplasmosis While on Atovaquone Prophylaxis Following Allogeneic Hematologic Stem Cell Transplantation
por: Chueng, Teresa A, et al.
Publicado: (2019)

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
por: Piñana, José Luis, et al.
Publicado: (2022)

Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to Candida auris Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of FKS1
por: Al-Obaid, Inaam, et al.
Publicado: (2022)

1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia
por: Zhang, Alexia Y, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_epj6rr1lso1ts31em3h59dlh3r